The Cost-Effectiveness and Budget Impact of Intravenous Versus Oral Proton Pump Inhibitors in Peptic Ulcer Hemorrhage

2006 ◽  
Vol 4 (8) ◽  
pp. 988-997.e2 ◽  
Author(s):  
Brennan M.R. Spiegel ◽  
Gareth S. Dulai ◽  
Brian S. Lim ◽  
Neel Mann ◽  
Fasiha Kanwal ◽  
...  
Keyword(s):  
Peptic Ulcer ◽  
Cost Effectiveness ◽  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Budget Impact ◽  
Peptic Ulcer Hemorrhage ◽  
The Cost ◽  
Ulcer Hemorrhage

The cost-effectiveness of competing strategies for the prevention of recurrent peptic ulcer hemorrhage

2002 ◽  
Vol 97 (8) ◽  
pp. 1941-1950 ◽  
Author(s):  
Joshua Ofman ◽  
Joel Wallace ◽  
Enkhe Badamgarav ◽  
Chiun-Fang Chiou ◽  
James Henning ◽  
...  
Keyword(s):  
Peptic Ulcer ◽  
Cost Effectiveness ◽  
Peptic Ulcer Hemorrhage ◽  
The Cost ◽  
Ulcer Hemorrhage

The Cost-Effectiveness of IV Versus PO Proton Pump Inhibitor (PPI) Therapy in the Management of High-Risk Ulcer Hemorrhage

2005 ◽  
Vol 61 (5) ◽  
pp. AB156
Author(s):  
Brennan Spiegel ◽  
Brian Lim ◽  
Gareth S. Dulai ◽  
Neel Mann ◽  
Fasiha Kanwal ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
High Risk ◽  
Proton Pump Inhibitor ◽  
Proton Pump ◽  
The Cost ◽  
Ulcer Hemorrhage

scholarly journals ESTIMATION OF CLINICAL AND PHARMACOECONOMIC EFFICIENCY OF PROTON PUMP INHIBITORS DURING GASTROESOPHAGEAL REFLUX DISEASE (GERD) TREATMENT

2018 ◽  
Vol 25 (6) ◽  
pp. 160-163
Author(s):  
N. E. Shabanova ◽  
N. V. Korochanskaya ◽  
A. I. Ponomareva
Keyword(s):  
Cost Effectiveness ◽  
Gastroesophageal Reflux Disease ◽  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Gold Standard ◽  
Conservative Therapy ◽  
Cost Effectiveness Ratio ◽  
Dynamic Observation ◽  
History Of ◽  
The Cost

Aim. The study was conducted to estimate the clinical and pharmacoeconomic efficiency of proton pump inhibitors (PPIs) omeprazole and esomeprazole when GERD patients undergo a course of medical treatment.Materials and methods. 25 GERD patients with a history of the disease for more than 5 years were under observation in Krasnodar regional clinical hospital № 2 from 2017 till 2018. All the patients have been thoroughly examined. Conservative therapy included the «gold standard» of proton pump inhibitors. Evaluation of the efficiency included the number of disease relapses in the period of dynamic observation and the calculation of the cost-effectiveness ratio.Results. When patients were taking esomeprazole, the relapses of the GERD disease were rare. The cost-effectiveness ratio was lower.Conclusion. The use of esomeprazole during the treatment of GERD patients has lower economic expenditures. The relapses of the disease are also less frequent.

Sign in / Sign up

Export Citation Format

Share Document